C J L M Meijer
Overview
Explore the profile of C J L M Meijer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
4469
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Louwers J, Zaal A, Kocken M, Papagiannakis E, Meijer C, Verheijen R
Gynecol Obstet Invest
. 2014 Nov;
79(4):239-43.
PMID: 25413738
Background: The focus of testing the dynamic spectral imaging (DSI) colposcope has been on the technical characteristics and clinical performance. However, aspects from a patient's perspective are just as important....
12.
Geraets D, Cuschieri K, de Koning M, van Doorn L, Snijders P, Meijer C, et al.
J Clin Microbiol
. 2014 Sep;
52(11):3996-4002.
PMID: 25210073
The LMNX genotyping kit HPV GP (LMNX) is based on the clinically validated GP5+/6+ PCR, with a genotyping readout as an alternative for the more established enzyme immunoassay (EIA) detection...
13.
Uijterwaal M, Witte B, van Kemenade F, Rijkaart D, Ridder R, Berkhof J, et al.
Br J Cancer
. 2014 Feb;
110(6):1579-86.
PMID: 24518601
Background: Women with borderline/mildly dyskaryotic (BMD) cytology smears are currently followed up with repeat testing at 6 and 18 months. The objective of this study is to analyse the cross-sectional...
14.
Hesselink A, Heideman D, Steenbergen R, Gok M, van Kemenade F, Wilting S, et al.
Int J Cancer
. 2014 Jan;
135(4):880-6.
PMID: 24474183
Methylation markers were studied for their suitability to triage human papillomavirus (HPV)-positive women by testing self-collected cervico-vaginal lavage specimens. For this purpose, we analyzed 355 hrHPV-positive self-collected specimens with three...
15.
Dijkstra M, Snijders P, Arbyn M, Rijkaart D, Berkhof J, Meijer C
Ann Oncol
. 2014 Jan;
25(5):927-35.
PMID: 24445150
Cytology-based nation-wide cervical screening has led to a substantial reduction of the incidence of cervical cancer in western countries. However, the sensitivity of cytology for the detection of high-grade precursor...
16.
Heideman D, Hesselink A, van Kemenade F, Iftner T, Berkhof J, Topal F, et al.
J Clin Microbiol
. 2013 Aug;
51(11):3653-7.
PMID: 23985912
The Aptima HPV assay (Hologic Gen-Probe, San Diego, CA) is an FDA-approved assay for detecting human papillomavirus (HPV) E6/E7 mRNA from 14 high-risk HPV types. This study evaluated the clinical...
17.
Hesselink A, Meijer C, Poljak M, Berkhof J, van Kemenade F, van der Salm M, et al.
J Clin Microbiol
. 2013 May;
51(7):2409-10.
PMID: 23637297
This study showed that the Abbott RealTime High Risk HPV assay fulfilled cross-sectional clinical equivalence and reproducibility criteria of international consensus guidelines, which indicates that this assay can be considered...
18.
Geraets D, van Baars R, Alonso I, Ordi J, Torne A, Melchers W, et al.
J Clin Virol
. 2013 Mar;
57(2):125-9.
PMID: 23518442
Background: High-risk human papillomavirus (hrHPV) testing in cervical screening is usually performed on physician-taken cervical smears in liquid-based medium. However, solid-state specimen carriers allow easy, non-hazardous storage and transportation and...
19.
Turksma A, Bontkes H, Ruizendaal J, van den Heuvel H, Scholten K, Santegoets S, et al.
Hum Immunol
. 2013 Feb;
74(5):506-13.
PMID: 23376456
Monocyte derived dendritic cells (moDC) electroporated with tumor associated antigen derived mRNA can elicit specific T cells against tumor cells in vivo. IL21 has been shown to enhance activation and...
20.
Turksma A, Bontkes H, van den Heuvel H, de Gruijl T, von Blomberg B, Braakhuis B, et al.
Oral Dis
. 2012 Nov;
19(6):577-84.
PMID: 23176702
Background: The immune system plays an important role in tumour immune surveillance. Head and neck squamous cell carcinoma patients are often immune compromised. Objective: To chart the baseline levels of...